GlassScriptPhysician profile
Renee Dougherty
NPI 1609260835
$4,509.77
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $851 · 2021: $1,655 · 2022: $950 · 2023: $725 · 2024: $15.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,325.63 | 2021 | |
| Novo Nordisk INC | $975.06 | 2019-2023 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $521.87 | 2022-2023 | Vraylar, Ubrelvy, Qulipta |
| Abbott Laboratories | $266.90 | 2022-2023 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $243.74 | 2019-2023 | Airsupra, Breztri, Fasenra |
| Lilly USA, LLC | $200.57 | 2019-2023 | Mounjaro |
| Pfizer INC. | $172.58 | 2020-2023 | |
| Glaxosmithkline, LLC. | $162.04 | 2020-2024 | Shingrix |
| Merck Sharp & Dohme LLC | $106.53 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.17 | 2020-2023 | Jardiance |
| Amgen INC. | $70.38 | 2019-2023 | Repatha |
| Biohaven Pharmaceutical Holding Company LTD. | $70.27 | 2022 | |
| Eisai INC. | $60.37 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $38.01 | 2019-2022 | |
| Amarin Pharma, INC. | $36.79 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $27.99 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $27.94 | 2023 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $25.49 | 2022 | |
| Upsher-Smith Laboratories LLC | $21.43 | 2020 | |
| Exact Sciences Corporation | $15.54 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $14.62 | 2020 | |
| Horizon Therapeutics Plc | $13.14 | 2022 | |
| Adlon Therapeutics L.P. | $12.27 | 2020 | |
| Genentech USA, INC. | $11.96 | 2022 | |
| Sanofi Pasteur INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.